New Haven, CTNCT05558566Now EnrollingIRB Ready

Tourette Syndrome in Adolescence Clinical Trial in New Haven, CT

Access cutting-edge tourette syndrome in adolescence treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this New Haven location

Preparing your pre-screening questions…

Expert Care in New Haven

Access tourette syndrome in adolescence specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related tourette syndrome in adolescence treatment provided free

Apply for This New Haven Location

Check if you qualify for this tourette syndrome in adolescence clinical trial in New Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Haven site if eligible
  4. 4Begin participation

About This Tourette Syndrome in Adolescence Study in New Haven

This is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental intervention) or real-time fMRI neurofeedback (NF) from a control region (for the control intervention).

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

Boys and girls, 10 to 16 years of age
A current diagnosis of Tourette Syndrome (TS) or chronic tic disorder (CTD), with active tics that can be executed without head movement, and a YGTSS score of at least 13 (for TS participants) or at least 12 (for CTD participants)
Currently stable medication treatment and no planned changes in medication for the duration of the study.
Family residence within 2 hours of Yale Medical Center with ability and willingness to attend assessment and fMRI visits.
Children and their parents are expected to be able to speak and understand spoken English in order to participate in a clinical assessment of TS and related psychopathology.
Subjects will be free of: 1) metal medical implants or braces, 2) pregnancy, and will have 3) a body weight of less than 250 lbs. and 4) no claustrophobia.

Exclusion Criteria

Intelligence quotient below 80
Current diagnosis of autism spectrum disorder, bipolar or psychotic disorder or current suicidality
Significant medical condition such as heart disease, hypertension, liver or renal failure, pulmonary disease, seizure disorder
Recently initiated psychotherapy. Participation in the study will not be allowed within 8 weeks of the initiation of psychotherapy. Ongoing, concurrent psychotherapy (that was initiated at least 8 weeks previously) for the child will be allowed, but parents will be asked not to initiate any new psychotherapy for the child during the study
Subjects may also be excluded after the first MR scan if we are unable to localize the two regions in their brain that are used as targets for the active and control neurofeedback conditions.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Haven?

Yes, this clinical trial (NCT05558566) has an active research site in New Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Tourette Syndrome in Adolescence Treatment Options in New Haven, CT

If you're searching for tourette syndrome in adolescence treatment options in New Haven, CT, this clinical trial (NCT05558566) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced tourette syndrome in adolescence specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all tourette syndrome in adolescence clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in New Haven, CT

See all alzheimers disease clinical trials recruiting in New Haven — not just this study.

Browse Alzheimers Disease Trials in New Haven →

Browse More Trials by Condition

Alzheimers Disease TrialsEssential Tremor TrialsTourette Syndrome TrialsAtopic Dermatitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in New Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Haven, CT